Here’s What Makes Medtronic Stock A Better Pick Over This Pharmaceuticals Company

Looking at stock returns, Eli Lilly’s 55% growth is much better than Medtronic’s -16% change over the last twelve months.

About the Author

has written 23527 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com